2005-001258-26: An 8-week extension to a randomized, double blind, parallel group, active-controlled, multi-center, 14 week study to evaluate the effectiveness of a valsartan versus an amlodipine treatment stratgey in achieving blood presure control in patients with stage 1 or stage 2 hypertension or uncontrolled on present monotherapy |
|
|
| | 3/4 | 240 | Europe | valsartan, hydrochlorothiazide, amlodipine, Diovan, Esidrex, Diovan, Esidrex | Novartis Faarmacéutica S.A, Novartis Pharma Services AG, NOVARTIS FARMA | Essential hypertension | | 03/07 | | |